Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1

Conditions

Polycystic Ovary Syndrome 21Glioblastoma 5Endometrial Neoplasms 5Breast Neoplasms 5Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Prostatic Neoplasms 3Leukoplakia, Oral 3Insulin Resistance 3Ovarian Neoplasms 2Metabolic Syndrome 2Metabolic Diseases 2Medulloblastoma 2Infertility 2Erythroplasia 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Intraductal, Noninfiltrating 2Adenocarcinoma Of Esophagus 2Weight Loss 1Uterine Cervical Neoplasms 1Urothelial Cancer 1Thyroid Diseases 1TP53 Y220C Mutation 1Smoldering Multiple Myeloma 1Sarcoma 1Rectal Neoplasms 1Prostate Cancer Recurrent 1Prediabetic State 1Posterior Fossa Ependymal Tumor 1Pleural Effusion, Malignant 1

Interventions

aldesleukin 2Pharmaceutical Preparations 2Interleukin-2 2sugemalimab 1aflutinib 1X-Rays 1Pleurodesis 1Metformin 1Drug Therapy 1Cisplatin 1Catheters, Indwelling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pleural Effusion, Malignant × Metformin × 1 year × Clear all
NCT02122185 2026-03-27

Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

University of Chicago

Phase 2 Completed
111 enrolled 15 charts
GynecologicThoracic

Carcinoma, Ovarian Epithelial, Brenner Tumor, Fallopian Tube Neoplasms, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡